Equity ratings for PARENTERAL DRUGS LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of December 2021 and ending today, the 26th of January 2022. Click here to learn more.
PARENTERAL DRUGS LTD cannot be verified against its exchange. Apparently, PARENTERAL DRUGS is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.


Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. PARENTERAL DRUGS's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PARENTERAL DRUGS or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
PARENTERAL DRUGS LTD is not yet fully synchronised with the market data
PARENTERAL DRUGS LTD has some characteristics of a very speculative penny stock
The company has accumulated 1.1 B in total debt with debt to equity ratio (D/E) of 2.11, implying the company greatly relies on financing operations through barrowing. PARENTERAL DRUGS LTD has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported the revenue of 320.28 M. Net Loss for the year was (1.48 B) with profit before overhead, payroll, taxes, and interest of 255.68 M.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of PARENTERAL DRUGS's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
PARENTERAL DRUGS LTD (PARENTLD) is traded on Bombay Stock Exchange in India and employs 5 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 98.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PARENTERAL DRUGS's market, we take the total number of its shares issued and multiply it by PARENTERAL DRUGS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. PARENTERAL DRUGS LTD operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 29.82 M outstanding shares.
Check PARENTERAL DRUGS Probability Of Bankruptcy

PARENTERAL Stock Against Markets

Picking the right benchmark for PARENTERAL DRUGS stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PARENTERAL DRUGS stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PARENTERAL DRUGS is critical whether you are bullish or bearish towards PARENTERAL DRUGS LTD at a given time.
PARENTERAL DRUGS LTD cannot be verified against its exchange. Apparently, PARENTERAL DRUGS is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PARENTERAL DRUGS stock to make a market-neutral strategy. Peer analysis of PARENTERAL DRUGS could also be used in its relative valuation, which is a method of valuing PARENTERAL DRUGS by comparing valuation metrics with similar companies.
Check out Your Equity Center. Note that the PARENTERAL DRUGS LTD information on this page should be used as a complementary analysis to other PARENTERAL DRUGS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Other Tools for PARENTERAL Stock

When running PARENTERAL DRUGS LTD price analysis, check to measure PARENTERAL DRUGS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PARENTERAL DRUGS is operating at the current time. Most of PARENTERAL DRUGS's value examination focuses on studying past and present price action to predict the probability of PARENTERAL DRUGS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PARENTERAL DRUGS's price. Additionally, you may evaluate how the addition of PARENTERAL DRUGS to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated